Donor brain death significantly interferes with tolerance induction protocols

Transplant International

Volumn 22, Issue 4, 2009, Pages 482-493

  Francuski, Maja ^a   Reutzel Selke, Anja ^a   Weiss, Sascha ^a   Pascher, Andreas ^a   Jurisch, Anke ^a,b   Ulrich, Frank ^a   Schumacher, Guido ^a   Faber, Wladimir ^a   Kohler, Sven ^a   Volk, Hans Dieter ^a   Neuhaus, Peter ^a   Tullius, Stefan G ^b   Pratschke, Johann ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Brain death; Experimental transplantation; Tolerance strategies and mechanisms

Indexed keywords

CD4 ANTIBODY; CD5 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BRAIN DEATH; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOHISTOLOGY; INFLAMMATORY INFILTRATE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; MALE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEINURIA; RAT; TRANSPLANTATION TOLERANCE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; BRAIN DEATH; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; RATS; RATS, INBRED F344; RATS, INBRED LEW; TRANSPLANTATION TOLERANCE;

EID: 61849102233     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00776.x     Document Type: Article

References (33)

1. Merts PM. Physiology of the brain death. In : Tilney NL, Strom TB, Paul LC, eds. Transplantation Biology: Cellular and Molecular Aspects. Philadelphia : Lippincott, 1996 : 275 pp.
2. Pratschke J, Tullius SG, Neuhaus P. What can be learned from brain-dead models? Transpl Int 2005 18 : 15.
3. Novitzky D. Detrimental effects of brain death on the potential organ donor. Transplant Proc 1997 29 : 3770.
4. Pratschke J, Tullius SG, Neuhaus P. Brain death associated ischemia/reperfusion injury. Ann Transplant 2004 9 : 78.
5. Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV. Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation 2003 75 : 2001.
6. Peeters P, Terryn W, Vanholder R, Lameire N. Delayed graft function in renal transplantation. Curr Opin Crit Care 2004 10 : 489.
7. Pratschke J, Wilhelm MJ, Kusaka M, et al. Accelerated rejection of rat renal allografts from brain-dead donors. Ann Surg 2000 232 : 263.
8. Pratschke J, Wilhelm MJ, Laskowski I, et al. Influence of donor brain death on chronic rejection of renal transplants. J Am Soc Nephrol 2001 12 : 2474.
9. Kirk AD. Crossing the bridge: large animal models in translational transplantation research. Immunol Rev 2003 196 : 176.
10. Chen ZK, Cobbold SP, Waldmann H, Metcalfe S. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 1996 62 : 1200.
11. Onodera K, Volk HD, Ritter T, Kupiec-Weglinski JW. Thymus requirement and antigen dependency in the "infectious" tolerance pathway in transplant recipients. J Immunol 1998 160 : 5765.
12. Siegling A, Lehmann M, Riedel H, et al. A non-depleting anti-rat CD4 monoclonal antibody that suppresses T helper 1-like, but not T helper 2-like intragraft lymfokine secretion induces long-term survival of renal allografts. Transplantation 1994 57 : 464.
13. Risch K, Heemann U, Graser E, et al. Assessment of chronic rejection in permanent accepted renal allografts in anti-CD4 treated rats. Clin Nephrol 1996 45 : 358.
14. Risch K, Becker G, Graser E, et al. Inhibition of chronic rejection after kidney transplantation by anti-CD4 treatment. Transplant Proc 1997 29 : 328.
15. Lehmann M, Sternkopf F, Metz F, et al. Induction of long-term survival of rat skin allografts by a novel, highly efficient anti-CD4 monoclonal antibody. Transplantation 1992 54 : 959.
16. Lehmann M, Graser E, Risch K, et al. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells. Transplantation 1997 64 : 1181.
17. Motoyama K, Arima T, Lehmann M, Flye MW. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration. Surgery 1997 122 : 213.
18. Kohlhaw K, Sack U, Lehmann I, et al. The monoclonal anti-CD4 antibody RIB 5/2 induces donor-specific tolerance in the high-responder liver transplant model in the rat. Transplant Proc 2001 33 : 2371.
19. Motoyama K, Arima T, Yu S, Lehmann M, Flye MW. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration. Transplantation 2000 69 : 285.
20. Otomo N, Margenthaler JA, Motoyama K, et al. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration. J Surg Res 2001 98 : 59.
21. Janeway C, Travers P, Walport M, Shlomchik MJ. Immunobiology: The Immune System in Health and Disease, 5th edn. New York : Garland Publishing, 2001 : 107 pp.
22. Sawitzki B, Lehmann M, Vogt K, et al. Bag-1 up-regulation in anti-CD4 mAb treated alloactivated T cells confers resistance to apoptosis. Eur J Immunol 2002 32 : 800.
23. Sawitzki B, Kieselbach B, Fisser M, et al. IFNγ regulation in anti-CD4 antibody-induced T cell unresponsiveness. J Am Soc Nephrol 2004 15 : 695.
24. Takada M, Nadeau KC, Hancock WW, et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998 65 : 1533.
25. Pratschke J, Kofla G, Wilhelm MJ, et al. Improvements in early behaviour of rat kidney allografts after treatment of the brain-dead donor. Ann Surg 2001 234 : 732.
26. Chen L, Wang T, Zhou P, et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006 6 : 2282.
27. Thornley TB, Brehm MA, Markees TG, et al. TLR agonists abrogate costimulation blockade-induced prologation of skin allografts. J Immunol 2006 176 : 1561.
28. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell mediated suppression by dendritic cells. Science 2003 299 : 1033.
29. Weiss S, Kotsch K, Francuski M, et al. Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 2007 7 : 1584.
30. Wu HS, Zhang JX, Wang L, et al. Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 2004 3 : 250.
31. Zhai Y, Shen XD, O'Connell R, et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004 173 : 7115.
32. Land WG. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation 2005 79 : 505.
33. Tullius SG, Heemann U, Hancock WW, Azuma H, Tilney NL. Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg 1994 220 : 425.